Active controlled 8 week study to evaluate Entresto vs enalapril...
PioneerHF: A multicenter, randomized, double-blind, double dummy, parallel group, active controlled 8 week study to evaluate Entresto vs enalapril on changes in NT-pro-BNP and safety and tolerability of in-hospital initiation of Entresto compared to enalapril in HFrEF patients who have been stabilized following hospitalization for ADHF. Done only at SMC
Questions: Call Mary Soltau 303-703-2191 or Rebecca Wimmer 303-715-2275